Navigation Links
Pharmasset Initiates First Time in Human Study of PSI-7851 for the Treatment of Hepatitis C (HCV)
Date:3/31/2009

PRINCETON, N.J., March 31 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS) announced today that dosing has started in a phase 1, single ascending dose (SAD) study in healthy volunteers with PSI-7851, a second generation nucleotide analog polymerase inhibitor of hepatitis C virus (HCV). Pharmasset filed an Investigational New Drug Application (IND) with the Food and Drug Administration (FDA) earlier this quarter.

"This is a significant milestone for Pharmasset. PSI-7851 is a wholly owned, second generation nucleotide analog that was discovered by Pharmasset scientists" stated Dr. Michelle Berrey, Pharmasset's Chief Medical Officer. "We continue to see nucleos(t)ide inhibitors as having the potential to be the cornerstone of future HCV treatment, given their higher barrier to resistance and antiviral activity across multiple HCV genotypes, characteristics that set them apart from other HCV drug classes. We look forward to reporting the first antiviral data with PSI-7851 in the second half of 2009."

About PSI-7851

PSI-7851 is a uridine nucleoside analog currently in developed for the treatment of chronic HCV infection. PSI-7851 has demonstrated in vitro anti-HCV activity with EC(50) values of 90 +/- 60 nM, which is approximately 15- to 20-fold more potent than the active metabolite of Pharmasset's first generation nucleoside polymerase inhibitor, R7128. In vitro studies of PSI-7851 have not shown evidence of any mitochondrial or other cellular toxicities that may be associated with some nucleoside analogs. The half-life of the triphosphate in primary human hepatocytes is approximately 38 hours, which suggests the possibility for once-daily dosing. Like R7128, PSI-7851 has demonstrated in vitro activity against all of the most common HCV genotypes.

About Pharmasset'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Pharmasset Reports Fiscal Year End 2008 Financial Results
2. Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C
3. Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications
4. Pharmasset to Present at the UBS Global Life Sciences Conference on Wednesday, September 24th
5. Pharmasset Reports Financial Results for Quarter Ended June 30, 2008
6. Pharmasset Reports Preliminary Results of a 4-week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
7. Pharmasset Announces Initiation of Combination Study of Clevudine and Viread(R) for HBV by French National Agency for Research on AIDS and Viral Hepatitis (ANRS)
8. Pharmasset Receives Notice of Allowance
9. Pharmasset Nominates PSI-7851 as a Lead Development Candidate for the Treatment of Chronic Hepatitis C
10. Pharmasset Commences Dosing R7128 Cohorts 3 and 4 for the Treatment of Chronic Hepatitis C
11. Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... ZURICH , May 28, 2015  Maetrics ( ... the life sciences sector, wrapped up a successful conference, ... the Medical Technology industry," today in Zurich ... ( http://www.maetrics.ch ) and its Switzerland ... regulation on the Medical Technology field to an exclusive ...
(Date:5/28/2015)... 28, 2015 The controversy surrounding the ... and myomectomies (procedures to remove uterine fibroids) continues, ... is investigating Johnson & Johnson,s Ethicon, Inc. unit, ... devices. According to the report published by The ... the FBI is trying to determine what the ...
(Date:5/28/2015)... 28, 2015 Isis Pharmaceuticals, Inc. (NASDAQ: ... WebcastWhen: , Thursday, June 4 at 1:00 p.m. ET ... Live on the Internet.  Simply log onto our website ... the live event, a replay of the webcast will ... . ABOUT ISIS PHARMACEUTICALS, INC. Isis is ...
Breaking Medicine Technology:Maetrics Hosts Innovative Medical Cluster Event in Switzerland 2Power Morcellator Attorneys at Bernstein Liebhard LLP Comment on Report That FBI Is Investigating Ethicon Morcellators 2Power Morcellator Attorneys at Bernstein Liebhard LLP Comment on Report That FBI Is Investigating Ethicon Morcellators 3Webcast Alert: Akcea Therapeutics Conference Call 2Webcast Alert: Akcea Therapeutics Conference Call 3
... 2011 Valeant Pharmaceuticals International, Inc. (NYSE: ... March 10, 2011, the company completed its previously ... About Valeant Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) ... manufactures and markets a broad range of pharmaceutical ...
... Inc. (Nasdaq: GNVC ) announced financial results for ... the year ended December 31, 2010, the Company reported a ... with a net loss of $18.4 million, or $0.19 per ... the year with $35.2 million in cash, cash equivalents, and ...
Cached Medicine Technology:GenVec Reports Fourth Quarter and 2010 Year-End Financial Results 2GenVec Reports Fourth Quarter and 2010 Year-End Financial Results 3GenVec Reports Fourth Quarter and 2010 Year-End Financial Results 4GenVec Reports Fourth Quarter and 2010 Year-End Financial Results 5GenVec Reports Fourth Quarter and 2010 Year-End Financial Results 6GenVec Reports Fourth Quarter and 2010 Year-End Financial Results 7GenVec Reports Fourth Quarter and 2010 Year-End Financial Results 8
(Date:5/29/2015)... AB (PRWEB) May 29, 2015 External Counterpulsation, ... great heart disease treatment for patients. The Heart Fit Clinic ... and has released a raving review from patients who are ... Fit Clinic and underwent 35 treatments of ECP treatment and ... be seen here. Not only does the clinic perform this ...
(Date:5/29/2015)... 29, 2015 An organizational consultant and ... is losing his memory and may be suffering from ... both his professional life and in his uncertain relationship ... a hob-knobbing career working with corporate and government movers ... as multiple family members around him are being diagnosed ...
(Date:5/29/2015)... May 29, 2015 Testosterone Centers of Texas ... area, is opening a new center in the Mid-Cities area ... of the Mid Cities. Located on the south side of ... Hurst, the new testosterone center will open in May and ... suffer from low testosterone. , Like TCT’s other testosterone clinics, ...
(Date:5/29/2015)... 2015 The 3D Certificate program is ... the business, finance, and engineering aspects of evaluating 3D ... technology, an expansion in their existing 3D investment, or ... of 3D technology in manufacturing in various fields, will ... will include courses that cover the following topics: state ...
(Date:5/29/2015)... Thursday, May 21st was the inaugural Red ... walks of life came together to raise money for kids ... a campaign dedicated to raising money for children and young ... people laugh, the people at Hands-On Seminars decided to host ... they provided food, fun and laughter to their visitors, while ...
Breaking Medicine News(10 mins):Health News:External Counterpulsation at Heart Fit Clinic Receives Raving Review 2Health News:‘Forgetful’ Professor Struggles With Dementia in Compelling New Novel 2Health News:Testosterone Clinics in Colleyville — TCT opens Hurst Location 2Health News:Testosterone Clinics in Colleyville — TCT opens Hurst Location 3Health News:Second Cohort in 3D Certificate Program to Launch in August by Graduate School 2Health News:Second Cohort in 3D Certificate Program to Launch in August by Graduate School 3Health News:Groups, such as Hands-On Physical Therapy, Across the Country, Host Their Own Events and Make the Inaugural Red Nose Day a Huge Success 2
... Effect of mutation blunted in people with above-average activity scores, ... activity may reduce the risk of obesity in people with ... (BMI), says a U.S. study. , Recent research has ... mass and obesity associated with the (FTO) gene. The ...
... provoking manuscript addressing key challenges facing the industry. , ... ... -- From pioneering research and profound insight into the inner ... addressing key challenges facing the industry. The article is published ...
... Sept. 8 The nation faces,challenges in utilizing ... health, according to a NASA-sponsored report issued Monday,by ... report examines the computer-based decision support tools that ... in areas such as,agricultural productivity, air quality, renewable ...
... Celebrates its 50th anniversary this holiday season, ... nonprofit,Minneapolis-based Courage Center, announces its new 2008 Courage ... Courage Cards is,celebrating its 50th anniversary as a ... announce our 2008 Courage Cards artists:, Bonnie ...
... at Children,s Hospital of ... ... Worldwide, Inc. (NYSE: HOT ) newest lifestyle brand, which,opened in ... 2008 by welcoming home and congratulating Olympic,Gold Medalist Brendan Hansen., ...
... Samuels, CEO of The,Marketing Doctor LLC, is happy ... ... fertility specialist Dr. Peyman Saadat of Tyler,Medical ... well-respected fertility,specialist in the medical field and The ... In addition they have created strategic alliances,with celebrities, ...
Cached Medicine News:Health News:Vigorous Exercise Aids Those With Obesity-Related Gene 2Health News:New Paper Reveals Reasons for Payer Discontent with Disease Management 2Health News:Report Explores Use of Earth Data to Support National Priorities 2Health News:Report Explores Use of Earth Data to Support National Priorities 3Health News:Courage Cards Announces 2008 Fine Art Holiday Greeting Card Collection 2Health News:Courage Cards Announces 2008 Fine Art Holiday Greeting Card Collection 3Health News:Courage Cards Announces 2008 Fine Art Holiday Greeting Card Collection 4Health News:Courage Cards Announces 2008 Fine Art Holiday Greeting Card Collection 5Health News:Courage Cards Announces 2008 Fine Art Holiday Greeting Card Collection 6Health News:Courage Cards Announces 2008 Fine Art Holiday Greeting Card Collection 7Health News:Courage Cards Announces 2008 Fine Art Holiday Greeting Card Collection 8Health News:aloft(SM) hotels Congratulates Hometown Olympic Swimmer and Gold Medalist Brendan Hansen Friday, September 12, 2008 2